Get started

XLV

$CI healthcear leader near 52wk highCigna Corp sells healthcear memberships for dental, medical and other servicesa like. For the six months ended 30 June 2022, Cigna Corp revenues increased 6% to $89.07B. Net income increased 4% to $2.74B. Breakout after breakout NYSE:CI is one of the few S&P 500 stocks that pass my trend template. As long the price stays above $272 I'm long. The On Balance Volume confirms the uptrend also making higher lows. Is always great to see volume confirming price action. But I'll wait for my ideal buy signal which is at $293.50. Let's see what happens.
NYSE:CILong
by dpuleo19
Healthcare leader $PRGO making a shark pattern Perrigo is in the Medical-Generic Drugs Group, they develop, manufactures, markets, and distributes private label self-care products, including cough, cold, and allergy products, analgesics, gastrointestinal products, smoking cessation products, infant formula and food products. IBD gives it a #1 rank in its industry. PRGO made its major low in May while XLV made it in late June. That's very good relative strength. Now, after the price broke above its 200-day MA, its been forming a base giving a good opportunity to buy. The price is making shark pattern with a pivot buy at $43.01. I'll leave a STOP BUY at that level.
NYSE:PRGOLong
by dpuleo19
Anthem, Inc. $ANTM flashing a VCPAnthem, Inc. is a provider of health insurance in the United States and is ranked 23rd on the Fortune 500. Fundamentals are very strong, it has an average YoY revenue growth of +14% for the las three quarters, and the last two quarters had EPS and Margin growth over the hundreds. IBD is giving NYSE:ANTM a #1 rank in its industry group and a 94 relative strength rating. That is synonymous of good fundamentals accompanied by very good technicals. Relative to the NASDAQ, the index has done three lower lows as NYSE:ANTM has done three higher lows. That is the kind of action a future leader does. Also, if you compare it against its sector AMEX:XLV , is doing way better. For the las 5 weeks, the price has been making a classic VCP with a pivot buy above $472. Today had a bad close but with low volume, that is a good sign. But, as the market is still in a correction, breakouts aren't working very well. Is time to be cautios so, if the breakout happens I'll buy 1/4 of my typical position sizing.
ALong
by dpuleo19
2
Healthcare is still in a bull market - be longAt the start of 2022, healthcare stocks have gotten killed, especially anything that was a winner in the past 1-2 years. A lot of people are getting rather bearish, but they shouldn't be. The fundamentals favor healthcare still in many ways, and momentum is still rather strong. We already got the breakout in healthcare stocks, and we just got the retest, which was enough to scare a lot of people out. Now is a great entry for a long position, coming out of a short consolidation into a potential new bull phase.
AMEX:XLVLong
by GTStockmaster